Pharmacokinetic and pharmacodynamic drug interactions: implications for abuse liability testing.
Sellers
E M
EM
Psychopharmacology Program, Addiction Research Foundation, Toronto, Ontario.
Busto
U
U
Kaplan
H L
HL
D004341:Drug Evaluation; D004347:Drug Interactions; D006801:Humans; D013287:Illicit Drugs / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D019966:Substance-Related Disorders / Q000628:therapy
D013287:Illicit Drugs; D011619:Psychotropic Drugs